We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Viral Load Trends in HIV Patients

By HospiMedica staff writers
Posted on 11 Oct 2000
A study of the viral load record of more than 600,000 HIV patients showed that patients who were more frequently monitored had greater suppression of viral load. This finding supports the belief that frequent blood monitoring and associated adjustments in therapy lead to more accurate intervention by treating physicians. The study was a collaborative effort among the University of North Carolina's Center for AIDS Research, the School of Public Health's biostatistical department, and Laboratory Corporation of America (LabCorp, Burlington, NC, USA).

LabCorp examined more than 600,000 test results and reported the following trends. The number of patients with undetectable viral load has risen dramatically, from 9% in 1996 to 44% by the end of 1999. Patients with lower initial viral loads were more likely to have suppressed viral loads. Viral rebound occurred in more than half the patients within a year. Male patients, older patients, or patients from the western part of the United States were more likely to have undetectable viral loads. Pediatric patients had the highest initial viral loads and were least likely to have suppressed viral loads.

LabCorp, the first U.S. laboratory to offer polymerase chain reaction (PCR) testing for early detection of HIV infection, now offers HIV genotyping and phenotyping for resistance testing. Specialists at the center's infectious disease laboratory focus on molecular diagnostics, using PCR and DNA probes to improve patient care by detecting, identifying, and quantifying pathogens.

The results from this study will provide HIV researchers and care providers with a clearer understanding of the factors associated with greater suppression of HIV viral load, said Dr. Hawazin Faruki, lead author of the study and LabCorp's vice president of operations
for the Center for Molecular Biology and Pathology.



Related Links:
Laboratory Corporation of America

Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Surgical Booms
AIRport
New
Carotid Artery Stent
Roadsaver

Latest Patient Care News

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization